Cargando…

Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease

BACKGROUND: Recent studies have shown that oxidative stress (OS) is the most important indicator in the pathogenesis of Alzheimer's disease (AD), but the results in previous studies are conflicting. This study aimed to assess the plasma levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) as DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Moslemnezhad, Ameneh, Mahjoub, Soleiman, Moghadasi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913710/
https://www.ncbi.nlm.nih.gov/pubmed/27386059
_version_ 1782438446295416832
author Moslemnezhad, Ameneh
Mahjoub, Soleiman
Moghadasi, Mehdi
author_facet Moslemnezhad, Ameneh
Mahjoub, Soleiman
Moghadasi, Mehdi
author_sort Moslemnezhad, Ameneh
collection PubMed
description BACKGROUND: Recent studies have shown that oxidative stress (OS) is the most important indicator in the pathogenesis of Alzheimer's disease (AD), but the results in previous studies are conflicting. This study aimed to assess the plasma levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) as DNA oxidative damage marker and total antioxidant capacity (TAC) in patients with AD versus control group. METHODS: Thirty patients with AD and 30 sex-and age-matched healthy subjects were studied. Diagnosis of AD was based on National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's disease and Related Disorders Association (NINCDS/ADRDA) criteria. Also for the patients, Mini-Mental State Examination (MMSE), computed tomography (CT) scan and brain magnetic resonance imaging (MRI) were done. Plasma levels of 8-OHdG and TAC were measured by competitive ELISA method and ferric reducing antioxidant power (FRAP) assay, respectively. RESULTS: Plasma levels of 8-OHdG was significantly higher in AD compared to control group (p<0.001), while the total antioxidant was significantly lower in patients compared to controls (p=0.002). The value of area under the ROC curve for 8-OHdG and TAC in discriminating AD from controls were 0.87 and 0.32, respectively. CONCLUSION: Our results indicate a link between oxidative stress and AD indicating a possible contributive role of these markers in the development of AD and as an indicator in the discrimination of AD from healthy controls.
format Online
Article
Text
id pubmed-4913710
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Babol University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-49137102016-07-06 Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease Moslemnezhad, Ameneh Mahjoub, Soleiman Moghadasi, Mehdi Caspian J Intern Med Original Article BACKGROUND: Recent studies have shown that oxidative stress (OS) is the most important indicator in the pathogenesis of Alzheimer's disease (AD), but the results in previous studies are conflicting. This study aimed to assess the plasma levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) as DNA oxidative damage marker and total antioxidant capacity (TAC) in patients with AD versus control group. METHODS: Thirty patients with AD and 30 sex-and age-matched healthy subjects were studied. Diagnosis of AD was based on National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's disease and Related Disorders Association (NINCDS/ADRDA) criteria. Also for the patients, Mini-Mental State Examination (MMSE), computed tomography (CT) scan and brain magnetic resonance imaging (MRI) were done. Plasma levels of 8-OHdG and TAC were measured by competitive ELISA method and ferric reducing antioxidant power (FRAP) assay, respectively. RESULTS: Plasma levels of 8-OHdG was significantly higher in AD compared to control group (p<0.001), while the total antioxidant was significantly lower in patients compared to controls (p=0.002). The value of area under the ROC curve for 8-OHdG and TAC in discriminating AD from controls were 0.87 and 0.32, respectively. CONCLUSION: Our results indicate a link between oxidative stress and AD indicating a possible contributive role of these markers in the development of AD and as an indicator in the discrimination of AD from healthy controls. Babol University of Medical Sciences 2016 /pmc/articles/PMC4913710/ /pubmed/27386059 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Moslemnezhad, Ameneh
Mahjoub, Soleiman
Moghadasi, Mehdi
Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease
title Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease
title_full Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease
title_fullStr Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease
title_full_unstemmed Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease
title_short Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease
title_sort altered plasma marker of oxidative dna damage and total antioxidant capacity in patients with alzheimer's disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913710/
https://www.ncbi.nlm.nih.gov/pubmed/27386059
work_keys_str_mv AT moslemnezhadameneh alteredplasmamarkerofoxidativednadamageandtotalantioxidantcapacityinpatientswithalzheimersdisease
AT mahjoubsoleiman alteredplasmamarkerofoxidativednadamageandtotalantioxidantcapacityinpatientswithalzheimersdisease
AT moghadasimehdi alteredplasmamarkerofoxidativednadamageandtotalantioxidantcapacityinpatientswithalzheimersdisease